Alteration of Serum Cystatin-C Levels after Hemodialysis in Dogs with Kidney Disease

被引:1
|
作者
Ahn, Woonchan [1 ,2 ,3 ]
Kim, Tae Hyeong [4 ]
Lee, Taeho [3 ]
Ahn, Jin-Ok [1 ,2 ]
Choi, Jung Hoon [4 ]
Chung, Jin-Young [1 ,2 ]
机构
[1] Kangwon Natl Univ, Coll Vet Med, Dept Vet Internal Med, 1 Kangwondaehak Gil, Chuncheon Si 24341, Gangwon Do, South Korea
[2] Kangwon Natl Univ, Coll Vet Med, Inst Vet Sci, 1 Kangwondaehak Gil, Chuncheon Si 24341, Gangwon Do, South Korea
[3] Smart Anim Hosp Sinsa, Seoul 06026, South Korea
[4] Kangwon Natl Univ, Coll Vet Med, Dept Vet Anat, 1 Kangwondaehak Gil, Chuncheon Si 24341, Gangwon Do, South Korea
基金
新加坡国家研究基金会;
关键词
Cystatin-C; Dog; Hemodialysis; Kidney disease; Middle-molecular-weight proteins;
D O I
10.29261/pakvetj/2020.100
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Kidney diseases are common life-threatening diseases in small animals. To evaluate the efficiency of hemodialysis in kidney disease treatment, several low-molecular-weight biochemical markers can be assessed. Recently, middle-molecular-weight proteins such as cystatin-C have been investigated for use as alternative biomarkers to evaluate renal function and predict mortality, especially in human hemodialysis patients. The goal of this study is to assess changes in cystatin-C levels when performing low-flux hemodialysis with an ultraflux dialyzer in dogs with kidney disease. This was a retrospective study. A total of twenty hemodialysis sessions were included in the study. The concentrations of cystatin-C level before and after hemodialysis were determined by examining ELISA results. The cystatin-C concentration was significantly lower after hemodialysis than before hemodialysis (P=0.0016). Cystatin-C can be removed by using low-flux hemodialysis. Thus, cystatin-C can be considered a potential kidney function biomarker in dogs with kidney disease being treated with low-flux intermittent hemodialysis. (C) 2020 PVJ. All rights reserved
引用
收藏
页码:299 / 302
页数:4
相关论文
共 50 条
  • [31] 3 RFLPS AT THE 3' END OF THE CYSTATIN-C GENE, THE DISEASE GENE IN HEREDITARY CYSTATIN-C AMYLOID ANGIOPATHY (HCCAA) IN ICELAND
    PALSDOTTIR, A
    JONSDOTTIR, S
    ABRAHAMSON, M
    GRUBB, A
    JENSSON, O
    NUCLEIC ACIDS RESEARCH, 1990, 18 (24) : 7471 - 7471
  • [32] Comparative performance of serum cystatin-c versus serum creatinine in diabetic subjects
    Buysschaert, M
    Joudi, I
    Wallemacq, P
    Hermans, MP
    DIABETES & METABOLISM, 2003, 29 (04) : 377 - 383
  • [33] Early Diagnosis of Acute Kidney Injury After Heart Transplantation - The Prominent Role of Cystatin-C
    Hoskova, L.
    Franekova, J.
    Malek, I.
    Kautzner, J.
    Pirk, J.
    Szarszoi, O.
    Jabor, A.
    Viklicky, O.
    Melenovsky, V.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S61 - S61
  • [34] Comparative Study of Serum Cystatin C and Serum Creatinine Level in Before and After Hemodialysis
    Hawale, Dattu
    Ambad, Ranjit
    Bankar, Nandkishor
    Kotecha, Raunak
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (39A) : 102 - 106
  • [35] Classification of chronic kidney disease: Cystatin C or serum creatinine?
    Modi, Gopesh K.
    NATIONAL MEDICAL JOURNAL OF INDIA, 2014, 27 (02): : 87 - 89
  • [36] Chronic kidney disease stages classified by serum cystatin-C and incidence of hip fracture in the women's health initiative observational study
    LaCroix, A. Z.
    Lee, J.
    Wu, L.
    Cauley, J.
    Shlipak, M. G.
    Ott, S. M.
    Robbins, J.
    Curb, J. D.
    LeBoff, M.
    Jackson, R.
    Kooperberg, C.
    Bauer, D. C.
    Cummings, S. R.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S312 - S312
  • [37] ASSOCIATION OF NGAL AND CYSTATIN-C WITH KIDNEY FUNCTION IN CHILDREN WITH NEPHROTIC SYNDROME
    Gheissari, Alaleh
    Rezaii, Zahra
    Merrikhi, Alireza
    Madihi, Yayha
    Kelishadi, Roya
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 579 - 579
  • [38] KDIGO Guidelines and Kidney Transplantation: Is the Cystatin-C Based Recommendation Relevant?
    Masson, I.
    Maillard, N.
    Cavalier, E.
    Alamartine, E.
    Mariat, C.
    Delanaye, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 (08) : 2211 - 2214
  • [39] Response to letter to the editor 'Serum cystatin-C levels correlate with endothelial dysfunction in patients with the metabolic syndrome'
    Magnusson, M.
    Hedblad, B.
    Engstrom, G.
    Persson, M.
    Nilsson, P.
    Melander, O.
    JOURNAL OF INTERNAL MEDICINE, 2013, 274 (05) : 496 - 498
  • [40] Cystatin-C is associated with partial recovery of kidney function and progression to chronic kidney disease in living kidney donors Observational study
    Bang, Ji-Yeon
    Kim, Seon-Ok
    Kim, Sae-Gyul
    Song, Jun-Gol
    Hwang, Gyu Sam
    MEDICINE, 2017, 96 (05)